Sample Size Determination for Clinical Trials in Patients with Nonlinear Disease Progression

ISSN： 1054-3406

Source： Journal of Biopharmaceutical Statistics, Vol.16, Iss.1, 2006-01, pp. : 91-105

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Calculation of Tolerance Limits and Sample Size Determination for Clinical Trials with Dichotomous Outcomes

By Zaslavsky Boris G.

Journal of Biopharmaceutical Statistics, Vol. 17, Iss. 3, 2007-05 ,pp. : 481-491

Taylor & Francis Ltd

Access to resources Recommend Favorite

Sample Size Determination for Cost-Effectiveness Trials

By Willan Andrew R.

PharmacoEconomics, Vol. 29, Iss. 11, 2011-11 ,pp. : 933-949

Adis International

Access to resources Recommend Favorite

Sample Size Determination in Superiority Clinical Trials with Multiple Co-Primary Correlated Endpoints

By Sozu Takashi

Journal of Biopharmaceutical Statistics, Vol. 21, Iss. 4, 2011-07 ,pp. : 650-668

Taylor & Francis Ltd

Access to resources Recommend Favorite

Sample Size Determination for Three-Level Randomized Clinical Trials with Randomization at the First or Second Level

Journal of Biopharmaceutical Statistics, Vol. 24, Iss. 3, 2014-05 ,pp. : 579-599

Taylor & Francis Ltd

Access to resources Recommend Favorite

On Cost Effectiveness and Sample Size in Clinical Trials

By Augustinus A.M. Hart Marcel G.W. Dijkgraaf

PharmacoEconomics, Vol. 22, Iss. 10, 2004-01 ,pp. : 685-688

Adis International

Access to resources Recommend Favorite